Tina Olsson

AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer’s Disease

Gvido Cebers, Robert Alexander, Samantha Budd Haeberlein et al. · Journal of Alzheimer s Disease · 2016 · 87 citations

Medicine, Pharmacokinetics, Pharmacology +17

Population pharmacokinetic and pharmacodynamic analysis of plasma Aβ₄₀and Aβ₄₂following single oral doses of the BACE1 inhibitor AZD3839 to healthy volunteers

Angelica Quartino, Gunilla Huledal, Erik Sparve et al. · Clinical Pharmacology in Drug Development · 2014 · 17 citations

Medicine, Pharmacokinetics, Pharmacology +12

P1‐363: MONITORING THE SOLUBLE AMYLOID PRECURSOR PROTEIN ALPHA (SAPPA) AND BETA (SAPPB) FRAGMENTS IN PLASMA AND CSF FROM HEALTHY INDIVIDUALS TREATED WITH BACE INHIBITOR AZD3293 IN A MULTIPLE ASCENDING DOSE STUDY: PHARMACOKINETIC AND PHARMACODYNAMIC CORRELATE

Kina Höglund, Hugh Salter, Henrik Zetterberg et al. · Alzheimer s & Dementia · 2014 · 14 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17